413 related articles for article (PubMed ID: 34050913)
21. Specific Targeting of Plasma Kallikrein for Treatment of Hereditary Angioedema: A Revolutionary Decade.
Busse P; Kaplan A
J Allergy Clin Immunol Pract; 2022 Mar; 10(3):716-722. PubMed ID: 34838707
[TBL] [Abstract][Full Text] [Related]
22. Clinical features of genetically characterized types of hereditary angioedema with normal C1 inhibitor: a systematic review of qualitative evidence.
Bork K; Machnig T; Wulff K; Witzke G; Prusty S; Hardt J
Orphanet J Rare Dis; 2020 Oct; 15(1):289. PubMed ID: 33059692
[TBL] [Abstract][Full Text] [Related]
23. Hereditary angioedema with normal C1 inhibitor and factor XII mutation: a series of 57 patients from the French National Center of Reference for Angioedema.
Deroux A; Boccon-Gibod I; Fain O; Pralong P; Ollivier Y; Pagnier A; Djenouhat K; Du-Thanh A; Gompel A; Faisant C; Launay D; Bouillet L
Clin Exp Immunol; 2016 Sep; 185(3):332-7. PubMed ID: 27271546
[TBL] [Abstract][Full Text] [Related]
24. Nailfold Videocapillaroscopy Findings in Bradykinin-Mediated Angioedema.
Cesoni Marcelli A; Loffredo S; Petraroli A; Carucci L; Mormile I; Ferrara AL; Spadaro G; Genovese A; Bova M
J Investig Allergol Clin Immunol; 2021 Oct; 31(5):404-416. PubMed ID: 32301440
[TBL] [Abstract][Full Text] [Related]
25. Periodic Severe Angioedema without Exogenous Hormone Exposure.
Nabavi M; Bahrami S; Arshi S; Rezaeifar A; Bemanian MH; Fallahpour M; Shokri S; Tehrani H
Iran J Allergy Asthma Immunol; 2021 Feb; 20(1):120-124. PubMed ID: 33639628
[TBL] [Abstract][Full Text] [Related]
26. Hereditary angioedema: a current state-of-the-art review, III: mechanisms of hereditary angioedema.
Davis AE
Ann Allergy Asthma Immunol; 2008 Jan; 100(1 Suppl 2):S7-12. PubMed ID: 18220146
[TBL] [Abstract][Full Text] [Related]
27. Recent advances in the management of hereditary angioedema.
Hemperly SE; Agarwal NS; Xu YY; Zhi YX; Craig TJ
J Am Osteopath Assoc; 2013 Jul; 113(7):546-55. PubMed ID: 23843378
[TBL] [Abstract][Full Text] [Related]
28. HAE Pathophysiology and Underlying Mechanisms.
Zuraw BL; Christiansen SC
Clin Rev Allergy Immunol; 2016 Oct; 51(2):216-29. PubMed ID: 27459852
[TBL] [Abstract][Full Text] [Related]
29. Bradykinin and oxidative stress in patients with hereditary angioedema due to C1 inhibitor deficiency.
Obtułowicz K; Góralska J; Bogdali A; Dyga W; Obtułowicz A; Myszkowska D; Ziemianin M; Gruca A; Solnica B; Czarnobilska E
Pol Arch Intern Med; 2020 Feb; 130(2):79-88. PubMed ID: 31933486
[TBL] [Abstract][Full Text] [Related]
30. Improving patient outcomes in hereditary angioedema: reducing attack frequency using routine prevention with C1 inhibitor concentrate.
Dominas N; Hoffmann TK; Bas M; Greve J
BMJ Case Rep; 2014 May; 2014():. PubMed ID: 24850548
[TBL] [Abstract][Full Text] [Related]
31. A novel prophylaxis with C1-inhibitor concentrate in hereditary angioedema during erythema marginatum.
Kőhalmi KV; Veszeli N; Cervenak L; Varga L; Farkas H
Immunol Lett; 2017 Sep; 189():90-93. PubMed ID: 28577900
[TBL] [Abstract][Full Text] [Related]
32. Psychology and hereditary angioedema: A systematic review.
Savarese L; Mormile I; Bova M; Petraroli A; Maiello A; Spadaro G; Freda MF
Allergy Asthma Proc; 2021 Jan; 42(1):e1-e7. PubMed ID: 33404395
[No Abstract] [Full Text] [Related]
33. Diagnostic and therapeutic management of hereditary angioedema due to C1-inhibitor deficiency: the Italian experience.
Cancian M;
Curr Opin Allergy Clin Immunol; 2015 Aug; 15(4):383-91. PubMed ID: 26106828
[TBL] [Abstract][Full Text] [Related]
34. Elevated plasma levels of vascular permeability factors in C1 inhibitor-deficient hereditary angioedema.
Loffredo S; Bova M; Suffritti C; Borriello F; Zanichelli A; Petraroli A; Varricchi G; Triggiani M; Cicardi M; Marone G
Allergy; 2016 Jul; 71(7):989-96. PubMed ID: 26873113
[TBL] [Abstract][Full Text] [Related]
35. Hereditary angioedema with normal C1 inhibitor in a French cohort: Clinical characteristics and response to treatment with icatibant.
Bouillet L; Boccon-Gibod I; Launay D; Gompel A; Kanny G; Fabien V; Fain O;
Immun Inflamm Dis; 2017 Mar; 5(1):29-36. PubMed ID: 28250922
[TBL] [Abstract][Full Text] [Related]
36. Decreased adhesion to endothelium leads to elevated neutrophil granulocyte count in hereditary angioedema patients.
Kajdácsi E; Balla Z; Pólai Z; Cervenak L; Farkas H
Sci Rep; 2023 Aug; 13(1):13366. PubMed ID: 37591965
[TBL] [Abstract][Full Text] [Related]
37. Treatment of Hereditary Angioedema.
Caballero T
J Investig Allergol Clin Immunol; 2021 Feb; 31(1):1-16. PubMed ID: 33602658
[TBL] [Abstract][Full Text] [Related]
38. Unnecessary Abdominal Surgeries in Attacks of Hereditary Angioedema with Normal C1 Inhibitor.
Gutierrez M; Veronez CL; Rodrigues Valle SO; Gonçalves RF; Ferriani MPL; Moreno AS; Arruda LK; Aun MV; Giavina-Bianchi P; Alonso MLO; Pesquero JB; Grumach AS
Clin Rev Allergy Immunol; 2021 Aug; 61(1):60-65. PubMed ID: 33755867
[TBL] [Abstract][Full Text] [Related]
39. Treatment of episodes of hereditary angioedema with C1 inhibitor: serial assessment of observed abnormalities of the plasma bradykinin-forming pathway and fibrinolysis.
Joseph K; Tholanikunnel TE; Kaplan AP
Ann Allergy Asthma Immunol; 2010 Jan; 104(1):50-4. PubMed ID: 20143645
[TBL] [Abstract][Full Text] [Related]
40. A Missense Mutation of the Plasminogen Gene in a Japanese Family with Hereditary Angioedema with Normal C1 Inhibitor: Third Family Survey in Asia.
Yakushiji H; Yamagami K; Hashimura C; Iwasaki H; Horiuchi T
Intern Med; 2023 Jul; 62(13):2005-2008. PubMed ID: 36418094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
